Literature DB >> 28240837

Liver transplantation for severe alcoholic hepatitis- The PRO view.

Michael R Lucey1.   

Abstract

Although liver transplantation has become accepted as a life-saving treatment of last resort for most life-threatening liver disorders, the use of liver transplantation to rescue patients with severe alcoholic hepatitis unresponsive to medical therapy remains controversial. I propose the concepts that alcohol use disorder is an illness, that on occasion results in alcoholic liver disease and that treatment of alcoholic liver disease, including treatment of patients with severe alcoholic hepatitis, combines treatment of the alcohol use disorder and of alcoholic liver disease. From this I derive the following principal to govern selection of patients for liver transplantation of patients with alcohol use disorder: that alcohol use disorder should impact suitability for liver transplantation as a co-morbid disorder, in the same way as other common co-morbid disorders such as diabetes mellitus or systemic hypertension, are factored in the selection process. We should relate the risk of drinking relapse to the prognosis of the patient after transplantation, rather than in a binary construct of likelihood of maintaining abstinence vs drinking.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alcohol use disorder; alcoholic hepatitis; liver; transplantation

Mesh:

Year:  2017        PMID: 28240837     DOI: 10.1111/liv.13343

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  4 in total

1.  Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.

Authors:  Brian P Lee; Eric Vittinghoff; Christine Hsu; Hyosun Han; George Therapondos; Oren K Fix; David W Victor; Deepti Dronamraju; Gene Y Im; Michael D Voigt; John P Rice; Michael R Lucey; Sheila Eswaran; Po-Hung Chen; Zhiping Li; Haripriya Maddur; Norah A Terrault
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

2.  Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.

Authors:  Brian P Lee; Sumeyye Samur; Ozden O Dalgic; Emily D Bethea; Michael R Lucey; Ethan Weinberg; Christine Hsu; Mary E Rinella; Gene Y Im; Oren K Fix; George Therapondos; Hyosun Han; David W Victor; Michael D Voigt; Sheila Eswaran; Norah A Terrault; Jagpreet Chhatwal
Journal:  Gastroenterology       Date:  2019-04-15       Impact factor: 22.682

Review 3.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

4.  National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.

Authors:  Brian P Lee; Eric Vittinghoff; Jennifer L Dodge; Giuseppe Cullaro; Norah A Terrault
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.